Free Trial

Aytu BioPharma (AYTU) Institutional Ownership

Aytu BioPharma logo
$2.57 +0.02 (+0.78%)
Closing price 04:00 PM Eastern
Extended Trading
$2.59 +0.02 (+0.78%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Aytu BioPharma (NASDAQ:AYTU)

Current
Institutional Ownership
Percentage
33.49%
Number of
Institutional Buyers
(last 12 months)
13
Total
Institutional Inflows
(last 12 months)
$4.25M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$125.18K
Get AYTU Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aytu BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

AYTU Institutional Buying and Selling by Quarter

Aytu BioPharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026XTX Topco Ltd25,860$67K0.0%N/A0.241%
2/17/2026Diadema Partners LP305,788$795K0.1%+12.1%2.850%
2/17/2026Persistent Asset Partners Ltd79,415$206K0.1%+27.2%0.740%
2/17/2026Rothschild Wealth LLC20,000$52K0.0%N/A0.186%
2/12/2026DRW Securities LLC29,368$76K0.0%N/A0.274%
2/12/2026Renaissance Technologies LLC89,623$233K0.0%-5.8%0.835%
1/23/2026 Bellevue Asset Management LLC25,013$65K0.0%N/A0.245%
1/21/2026 Daytona Street Capital LLC10,000$26K0.0%N/A0.098%
1/16/2026 FNY Investment Advisers LLC31,600$82K0.0%+24,207.7%0.310%
11/14/2025Two Sigma Investments LP68,736$129K0.0%+96.2%0.675%
11/12/2025Dimensional Fund Advisors LP30,964$58K0.0%N/A0.304%
11/10/2025Persistent Asset Partners Ltd62,452$117K0.1%N/A0.613%
8/15/2025AWM Investment Company Inc.619,874$1.35M0.2%N/A6.903%
8/13/2025Stonepine Capital Management LLC812,676$1.77M1.7%+75.3%9.053%
7/30/2025 FNY Investment Advisers LLC35,921$78K0.0%N/A0.400%
7/15/2025Kanen Wealth Management LLC573,358$1.25M0.5%N/A6.385%
5/15/2025Armistice Capital LLC57,597$69K0.0%-61.6%0.934%
5/14/2025Stonepine Capital Management LLC463,721$556K0.5%+13.8%7.516%
2/17/2025Stonepine Capital Management LLC407,549$693K0.6%-18.6%6.627%
11/14/2024Stonepine Capital Management LLC500,958$1.18M0.7%+6.0%8.147%
8/15/2024Armistice Capital LLC252,000$736K0.0%N/A4.220%
8/9/2024Dimensional Fund Advisors LP23,551$69K0.0%+54.5%0.394%
8/16/2023Stonepine Capital Management LLC472,369$756K0.3%N/A12.497%
8/11/2023Stonepine Capital Management LLC472,369$756K0.3%N/A12.497%
2/7/2023Commonwealth Equity Services LLC309,558$58K0.0%+47.7%9.922%
11/4/2022Prudential Financial Inc.145,550$27K0.0%+257.2%0.233%


AYTU Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of AYTU shares?

During the previous two years, 15 institutional investors and hedge funds held shares of Aytu BioPharma. The most heavily invested institutionals were Stonepine Capital Management LLC ($1.77M), AWM Investment Company Inc. ($1.35M), Kanen Wealth Management LLC ($1.25M), Diadema Partners LP ($795K), Renaissance Technologies LLC ($233K), Persistent Asset Partners Ltd ($206K), and Two Sigma Investments LP ($129K).Learn more on Aytu BioPharma's institutional investors.

What percentage of Aytu BioPharma's stock is owned by institutional investors?

33.49% of Aytu BioPharma's stock is owned by institutional investors. Learn more on AYTU's institutional investor holdings.

Which institutional investors have been buying Aytu BioPharma's stock?

Of the 14 institutional investors that purchased Aytu BioPharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AWM Investment Company Inc. ($619.87K), Kanen Wealth Management LLC ($573.36K), Stonepine Capital Management LLC ($433.62K), Armistice Capital LLC ($252K), Persistent Asset Partners Ltd ($79.42K), FNY Investment Advisers LLC ($67.39K), and Dimensional Fund Advisors LP ($39.28K).

How much institutional buying is happening at Aytu BioPharma?

Institutional investors have bought a total of 1,953,189 shares in the last 24 months. This purchase volume represents approximately $4.25M in transactions.

Which of Aytu BioPharma's major shareholders have been selling company stock?

The following institutional investors have sold Aytu BioPharma stock in the last 24 months: Armistice Capital LLC ($92.40K), and Renaissance Technologies LLC ($5.50K).

How much institutional selling is happening at Aytu BioPharma?

Institutional investors have sold a total of 97,903 shares in the last 24 months. This volume of shares sold represents approximately $125.18K in transactions.



This page (NASDAQ:AYTU) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners